Connection
Tomoko Matsuo to Dipeptidyl-Peptidase IV Inhibitors
This is a "connection" page, showing publications Tomoko Matsuo has written about Dipeptidyl-Peptidase IV Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.101 |
|
|
|
-
Shimoda S, Iwashita S, Ichimori S, Matsuo Y, Goto R, Maeda T, Matsuo T, Sekigami T, Kawashima J, Kondo T, Matsumura T, Motoshima H, Furukawa N, Nishida K, Araki E. Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy. Endocr J. 2013; 60(10):1207-14.
Score: 0.101